BioCentury
ARTICLE | Distillery Therapeutics

Endocrine/Metabolic

June 20, 2018 7:05 PM UTC

Patient sample and mouse studies suggest inhibiting ANGPTL4 could help treat insulin resistance. In non-diabetic individuals, a loss-of-function mutation in ANGPTL4 was associated with low levels of f...

BCIQ Company Profiles

Regeneron Pharmaceuticals Inc.

BCIQ Target Profiles

Angiopoietin-like 4 (ANGPTL4)